Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

Shares of Moderna Inc. MRNA slipped 2.63% to $68.02 Thursday, on what proved to be an all-around favorable trading session ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $69.86 which represents a decrease of $-2.13 or -2.96% from the prior close of $71.99. The stock opened at $72.19 and touched a low of $69.82 ...

COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, ...

Florida officials are issuing conflicting statements with the Centers for Disease Control and Prevention about COVID-19 ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...

Chaffee County, CO - Chaffee County Public Health (CCPH) has been preparing for another active respiratory illness season and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...